Audrey Sue Lavoie

---

Audrey Lavoie MSc, Hon. BSc has extensive experience in pharmaceutical research, animal research, statistical analysis and regulatory affairs. In her work with the Canadian Center for Veterinary Biologics of the Canadian Food Inspection Agency she performed pre and post-licensing regulatory oversight of veterinary vaccines, diagnostic kits, and antibody products, as well as evaluated licensing submissions for these products. At Abbott Point of Care, she authored and edited laboratory protocols and reports, performed statistical analyses as well as coordinated with regulatory affairs, quality control and laboratory personnel to complete verifications of Abbott Point of Care’s experimental diagnostic medical device. As an employee of Pfizer Vaccines Research, she worked in both the laboratory and animal care facilities. She performed and validated laboratory assays, authored laboratory protocols, analyzed data as well as developed data analysis systems, and coordinated laboratory animal studies. As part of her Masters of Science research project on the effects of GLP-1 on type 2 diabetes mellitus, she completed a systematic literature review including statistical meta-analysis.

As a Scientific Affairs Coordinator with Paul Dick and Associates, she is involved with all aspects of product development, including the preparation of regulatory submissions for Health Canada and the Canadian Food Inspection Agency. Other responsibilities include attending and preparing for pre-submission meetings with Health Canada and the Canadian Food Inspection Agency. She conducts label revisions and French label translation and performs monitoring and statistical analysis of good clinical practice clinical trials. In addition to the above she conducts literature reviews, and market assessments and assists in the preparation of business and marketing plans.